No black box warning on record for Steglujan
As of the latest FDA labeling reviewed, Steglujan (ERTUGLIFLOZIN AND SITAGLIPTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Steglujan medicine page for the complete safety profile.